Astra Wealth Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$305K Buy
332
+16
+5% +$16.2K 0.18% 71
2025
Q4
$340K Buy
316
+32
+11% +$30.6K 0.2% 71
2025
Q3
$217K Buy
284
+9
+3% +$6.7K 0.14% 88
2025
Q2
$214K Sell
275
-22
-7% -$17.1K 0.16% 80
2025
Q1
$245K Buy
297
+35
+13% +$29.1K 0.22% 67
2024
Q4
$202K Buy
+262
New +$217K 0.19% 69

Other funds holding LLY

Astra Wealth Partners's LLY Position: Q1 2026 in Review

Astra Wealth Partners increased its Eli Lilly (LLY) stake by 5.1% in Q1 2026, buying an estimated $16.2K and bringing the position to 332 shares worth $305K. The position accounts for 0.18% of the portfolio, ranked #71.

Astra Wealth Partners first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $340K in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Astra Wealth Partners held 332 shares of Eli Lilly worth $305K as of Q1 2026.
  • Astra Wealth Partners bought 16 Eli Lilly shares in Q1 2026, an estimated $16.2K.
  • Eli Lilly made up 0.18% of Astra Wealth Partners's portfolio in Q1 2026, its #71 holding.
  • Astra Wealth Partners first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Astra Wealth Partners's Eli Lilly position peaked at $340K in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Astra Wealth Partners's 13F filing for Q1 2026, filed 6 May 2026.